Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Hile Bio-Technology Co's EV-to-FCF or its related term are showing as below:
SHSE:603718'
s EV-to-FCF Range Over the Past 10 Years
Min: -484.45 Med: 28.93 Max: 5094.48
Current: 28.11
During the past 13 years, the highest EV-to-FCF of Shanghai Hile Bio-Technology Co was 5094.48. The lowest was -484.45. And the median was 28.93.
SHSE:603718's EV-to-FCF is ranked worse than 65.22% of 345
companies
in the Biotechnology industry
Industry Median: 14.39
vs SHSE:603718: 28.11
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Hile Bio-Technology Co (SHSE:603718) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Hile Bio-Technology Co's PE Ratio (TTM) for today is calculated as:
Shanghai Hile Bio-Technology Co's share price for today is ¥2.86.
Shanghai Hile Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.490.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Hile Bio-Technology Co EV-to-FCF Related Terms
Shanghai Hile Bio-Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603718 vs VRTX, REGN, RVMD: EV-to-FCF Comparison
For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Hile Bio-Technology Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Hile Bio-Technology Co's EV-to-FCF falls into.
Shanghai Hile Bio-Technology Co's current Enterprise Value is ¥1,617.3 Mil.
Shanghai Hile Bio-Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥59.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Hile Bio-Technology Co (SHSE:603718) has a EV-to-FCF of 27.34 as of Aug. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Hile Bio-Technology Co and its competitors. This is near median its historical median of 28.93. According to the industry distribution chart, Shanghai Hile Bio-Technology Co ranks #225 out of 345 companies in the Biotechnology industry, placing it in the top 65.2%.
Is Shanghai Hile Bio-Technology Co's EV-to-FCF too high?
Shanghai Hile Bio-Technology Co's current EV-to-FCF of 27.34 is near median its 10-year median of 28.93. The Biotechnology industry median EV-to-FCF is 14.39. Shanghai Hile Bio-Technology Co's value of 27.34 is 90% above this industry median. Based on the distribution chart, Shanghai Hile Bio-Technology Co ranks #225 out of 345 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanghai Hile Bio-Technology Co has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Hile Bio-Technology Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Hile Bio-Technology Co ranks #225 out of 345 companies for EV-to-FCF. This places Shanghai Hile Bio-Technology Co in the lower half of its industry. The industry median EV-to-FCF is 14.39. Shanghai Hile Bio-Technology Co's value of 27.34 is 90% above this benchmark. While the company's 10-year median is 28.93 vs. the industry median of 14.39, Shanghai Hile Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.39, based on 345 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Hile Bio-Technology Co's current EV-to-FCF of 27.34 is 90% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Hile Bio-Technology Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Hile Bio-Technology Co's current EV-to-FCF is 27.34, which is near median its own 10-year median of 28.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Hile Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co (SHSE:603718) is currently considered Possible Value Trap. The stock's GF Value™ is ¥4.25, compared to a current price of ¥2.86 — trading 32.7% below its estimated fair value. The current EV-to-FCF is 27.34, which is near median its 10-year median of 28.93 and 90% above the Biotechnology industry median of 14.39. Shanghai Hile Bio-Technology Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Hile Bio-Technology Co (SHSE:603718), the current EV-to-FCF is 27.34 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Hile Bio-Technology Co (SHSE:603718) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co stock appears to be undervalued.
The current stock price of ¥2.86 is trading 32.7% below its estimated GF Value™ of ¥4.25.
GuruFocus considers Shanghai Hile Bio-Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603718:
EV-to-FCF: 27.34 (near median its 10-year median of 28.93)
GF Value™: ¥4.25 vs. price of ¥2.86 (32.7% below fair value)
Industry Position: 90% above the Biotechnology median (#225 of 345)
No single metric tells the full story. See the SHSE:603718 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
50GF Score
Get the complete analysis for SHSE:603718
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603718 has been successfully added to your 
